BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9159168)

  • 1. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
    DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
    Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
    Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular types I and II transforming growth factor-beta receptor expression: differential dependency on tyrosine kinases during induction by TGF-beta.
    Ward MR; Agrotis A; Jennings G; Bobik A
    FEBS Lett; 1998 Jan; 422(2):197-200. PubMed ID: 9490005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
    Lotz M; Ranheim E; Kipps TJ
    J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.
    Jung CW; Kim ES; Seol JG; Park WH; Lee SJ; Kim BK; Lee YY
    Leuk Res; 1999 Dec; 23(12):1105-12. PubMed ID: 10613355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor.
    Kornmann M; Tangvoranuntakul P; Korc M
    Int J Cancer; 1999 Oct; 83(2):247-54. PubMed ID: 10471535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.
    Lagneaux L; Delforge A; Bron D; Massy M; Bernier M; Stryckmans P
    Br J Haematol; 1997 Jun; 97(3):612-20. PubMed ID: 9207409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
    Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
    Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.
    Lagadec P; Raynal S; Lieubeau B; Onier N; Arnould L; Saint-Giorgio V; Lawrence DA; Jeannin JF
    Am J Pathol; 1999 Jun; 154(6):1867-76. PubMed ID: 10362813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
    Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
    Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H; Shaw AR; Mak A; Letarte M
    J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.
    Liu P; Menon K; Alvarez E; Lu K; Teicher BA
    Int J Oncol; 2000 Mar; 16(3):599-610. PubMed ID: 10675495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.